The DOI matches its Crossref record.
The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains
Abstract
Since the discovery of insulin and its receptor, the downstream elements responsible for the pleiotropic insulin signal have been difficult to define. The recently discovered insulin receptor substrate, IRS-1, provides an innovative and simple way to think about this problem: IRS-1 may mediate the control of various cellular processes by insulin. Overexpression of IRS-1 enhances insulin-stimulated DNA synthesis in Chinese hamster ovary cells, and microinjection of IRS-1 protein potentiates the maturation of Xenopus oocytes. We suspect that insulin signals are enabled when the activated insulin receptor kinase phosphorylates specific tyrosine residues in IRS-1. These phosphorylated sites associate with high affinity to cellular proteins that contain SH2 (src homology-2) domains. This association is specific and depends on the amino acid sequence surrounding the phosphotyrosine residue and the isoform of the SH2 domain. A growing number of SH2 domain–containing proteins have been identified, and we suspect that IRS-1 has the potential to simultaneously regulate many of them. We have only begun to identify the specific proteins that associate with phosphorylated IRS-1. One of them, the phosphatidylinositol 3′-kinase, is activated when the SH2 domains in its 85,000-Mr regulatory subunit bind to phosphorylated IRS-1. IRS-1 also interacts with other proteins such as SHPTP2, a novel SH2 domain–containing Tyr phosphatase, and GRB-2/sem-5, a protein that is implicated in p21ras signaling. The interaction between phosphorylated IRS-1 and multiple SH2 domain–containing proteins may ultimately explain the pleiotropic effects of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationMolecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
Self-citationModulation of Insulin Activities by Leptin
Cohen, B., Novick, D., & Rubinstein, M. (1996) · Science · doi:10.1126/science.274.5290.1185 · Cited by 716
A Grb2-associated docking protein in EGF- and insulin-receptor signalling
Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K., & Wong, A. J. (1996) · Nature · doi:10.1038/379560a0 · Cited by 677
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 549
Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1.
Sun, X. J., Crimmins, D. L., Myers, M. G., Miralpeix, M., & White, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7418 · Cited by 466
Self-citationThe insulin receptor: structure, function, and signaling
Lee, J., & Pilch, P. F. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.2.c319 · Cited by 450
Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M., & Holman, G. D. (1994) · Biochemical Journal · doi:10.1042/bj3000631 · Cited by 358
Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling.
Kotani, K., Yonezawa, K., Hara, K., Ueda, H., Kitamura, Y., Sakaue, H., Ando, A., Chavanieu, A., Calas, B., & Grigorescu, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06515.x · Cited by 356
Insulin Signal Transduction and the IRS Proteins
Myers, M. G., & White, M. F. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003151 · Cited by 332
Self-citationAminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
Almind, K., Bjørbaek, C., Vestergaard, H., Hansen, T., Echwald, S., & Pedersen, O. (1993) · The Lancet · doi:10.1016/0140-6736(93)92694-o · Cited by 325
Myers, M. G., Sun, X. J., & White, M. F. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90007-8 · Cited by 315
Self-citationMembrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus
Maddux, B. A., Sbraccia, P., Kumakura, S., Sasson, S., Youngren, J., Fisher, A., Spencer, S., Grupe, A., Henzel, W., Stewart, T. A., et al. (1995) · Nature · doi:10.1038/373448a0 · Cited by 309
Shepherd, P. R., Navé, B. T., & Siddle, K. (1995) · Biochemical Journal · doi:10.1042/bj3050025 · Cited by 277
Cognitive effects of insulin in the central nervous system
Park, C. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00016-1 · Cited by 270
Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
Yamauchi, K., Milarski, K. L., Saltiel, A. R., & Pessin, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.664 · Cited by 263
Myers, M. G., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., & White, M. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61974-5 · Cited by 261
Self-citationHitman, G. A., Hawrami, K., McCarthy, M. I., Viswanathan, M., Snehalatha, C., Ramachandran, A., Tuomilehto, J., Tuomilehto-Wolf, E., Nissinen, A., & Pedersen, O. (1995) · Diabetologia · doi:10.1007/s001250050309 · Cited by 124
Kitessa, S., & Abeywardena, M. (2016) · Nutrients · doi:10.3390/nu8080466 · Cited by 98
Richter, E. A., Bilan, P. J., & Klip, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00033.2024 · Cited by 64
Metadata
- Authors
- Myers, M. G., & White, M. F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1993-05-01
- Volume
- 42
- Issue
- 5
- Pages
- 643-650
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1981549168
- Cited by
- 229
- References
- 0
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.